How Will the ₹19,000 Cr AbbVie Deal Benefit the Company?
Synopsis: The share of this pharmaceutical company remains supported by strong growth guidance, improving global business momentum, and a Rs...
Synopsis: The share of this pharmaceutical company remains supported by strong growth guidance, improving global business momentum, and a Rs...